MDS Virtual Congress 2020 » Neuropharmacology

Meeting: MDS Virtual Congress 2020

4-Chlorokynurenine inhibits L-Dopa-induced dyskinesias in non-human parkinsonian primates

T. Di Paolo, M. Bourque, R. Snodgrass (Quebec City, QC, Canada)

Copper induced neurobehavioral features of Parkinson’s disease and oxidative stress and their abatement by Eugenol

A. Kumar, B. Sharma (Allahabad, India)

hUC-MSCs ameliorated CUMS-induced depression by modulating complement C3 signaling-mediated microglial polarization during astrocyte-microglia crosstalk

J. Li, H.L Wang, M.W Wang (Shijiazhuang, China)

Neuroprotective effects of allicin microemulsion against intrastriatal rotenone and manganese induced Parkinsonism in rats

S. Singh (Moga, India)

Oral treatment of the SOD1G93A transgenic mouse model of amyotrophic lateral sclerosis (ALS) with the neuro-inflammation inhibiting compound PRI-003

J. Post-Schulz, A. Schaffrath, A. Willuweit, D. Willbold, J. Kutzsche (Jülich, Germany)

Perillyl alcohol restores mitochondrial dysfunction and abridge NLRP3 inflammasomes activation in in-vitro and in-vivo model of Parkinson’s disease

P. Panda, S. Ahmed, V. Naidu (Kamrup, India)

Preclinical pharmacology and early clinical development of dopamine D1 positive allosteric modulators (D1PAMs) with therapeutic potential for neuropsychiatric disorders

K. Svensson, H. Meltzer, K. Biglan (Indianapolis, IN, USA)

« View all categories from the MDS Virtual Congress 2020.